Marietta Wu
Algemeen Directeur bij Burrill & Co. Venture Capital
Oorsprong van het eerstegraads netwerk van Marietta Wu
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 13 | |
The BayHelix Group
9
| Private Company | 9 | |
Crescendo Biologics Ltd.
 Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Crescendo Biologics Ltd. engages in the development of new medicines based on antibody fragment technology. Its products in pipeline in dermatology include CB001, a transformational Humabody-based topical biologic for psoriasis which combines exceptional activity against a validated target with a topical route of delivery to avoid systemic side effects. The firm?s oncology products in pipeline include Humabody Multi-Specific T-Cell Engagers, Humabody Antibody Drug Conjugates and Immune Checkpoint Inhibitors. The company was founded by Michael Anthony Romanos, David Rayll Brown and John Bradshaw on November 13, 2007 and is headquartered in Cambridge, the United Kingdom.
8
| Holding Company | Miscellaneous Commercial Services | 8 |
Shanghai Rarestone Health Tech Group Co. Ltd.
 Shanghai Rarestone Health Tech Group Co. Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Rarestone Health Tech Group Co. Ltd. is a Chinese company that focuses on rare disease therapy and self-management information through internet information. The company is based in Huangpu, China. The company also operates and promote medical devices and communication platforms. The CEO of the company is Shawn Xiang.
6
| Holding Company | Pharmaceuticals: Major | 6 |
Innoforce Pharmaceuticals Co. Ltd.
 Innoforce Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Innoforce Pharmaceuticals Co. Ltd. is a bioinnovation-enabling corporation located in the Hangzhou Bay Biotech Valley within the Hangzhou Airport Economic Demonstration Area. The founders and core management team have extensive international experience and expertise in technology innovation, product development, and business operations. The Chinese company's first phase of the campus covers 21 acres, including biologic process development laboratories, scale-up and R & D labs, and manufacturing facilities for protein, cell, and gene therapies. The company was founded in 2018 by Guo-Liang Yu, Yuling Li, and Zhenhua Wu. Dewan Zeng has been the CEO of the company since 2023.
6
| Holding Company | Pharmaceuticals: Major | 6 |
Eluminex Biosciences (Suzhou) Ltd.
 Eluminex Biosciences (Suzhou) Ltd. BiotechnologyHealth Technology Eluminex Biosciences (Suzhou) Ltd. is a privately held biotechnology company located in Suzhou, China. Eluminex Biosciences is committed to developing innovative pharmaceuticals, drug delivery systems, and regenerative tissue for significant unmet vision-threatening or lifestyle limiting ophthalmic diseases in various markets. The Chinese company focuses on ophthalmology and recombinant human collagen technology, with a goal to become a leading healthcare company in developing irreversible loss of optical quality of the cornea due to disease or damage, diabetic macular edema, and wet age-related macular degeneration. The company was founded in 2020 by Jin Zhong Zhang, who has been the CEO since then.
4
| Private Company | Biotechnology | 4 |
MEDx Translational Medicine Co., Ltd.
 MEDx Translational Medicine Co., Ltd. Medical DistributorsDistribution Services MEDx Translational Medicine Co., Ltd. is a leading Chinese innovative company in companion diagnostics and precision medicine in China. The company is based in Suzhou, China. MEDx collaborates with hundreds of world-renowned pharmaceutical companies and has been rewarded with many certifications, including China CNAS, ISO17025, and US CAP ISO 13485, among others. The company was founded in 2013 as Qiagen Translational Medicine Co., Ltd. With comprehensive technology platforms, high-quality systems, and strong IVD R&D experience, MEDx offers integrated solutions from biomarker discovery to patient stratification for drug clinical trials, IVD/CDX R&D, and commercialization. The company was founded in 2013 by Ya Fei Zhang, who has been the CEO since then.
1
| Holding Company | Medical Distributors | 1 |
Jing Medicine Technology Shanghai Ltd.
 Jing Medicine Technology Shanghai Ltd. BiotechnologyHealth Technology Jing Medicine Technology Shanghai Ltd. develops therapeutic monoclonal antibody and small molecule drugs. The private company is based in Shanghai, China.
1
| Private Company | Biotechnology | 1 |
Kira Pharmaceuticals (Hong Kong) Ltd.
 Kira Pharmaceuticals (Hong Kong) Ltd. Pharmaceuticals: MajorHealth Technology Kira Pharmaceuticals (Hong Kong) Ltd. manufactures pharmaceuticals. The private company is based in Hong Kong, Hong Kong.
1
| Private Company | Pharmaceuticals: Major | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Marietta Wu via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Public Communications Contact | |
| PFIZER, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| Rochester Christian University | College/University | Graduate Degree Doctorate Degree | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | General Counsel Corporate Officer/Principal | |
| HUTCHMED (CHINA) LIMITED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Crown Bioscience, Inc.
 Crown Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Crown Bioscience, Inc. provides biomedical outsourcing solutions. It provides syngeneic and xenograft tumor models and custom model development and drug testing. The firm produces antibodies for therapeutic, diagnostic and theranostic applications. It also offers preclinical and drug development for anti-cancers therapeutics. The company was founded by Dr. Yiyou Chen, Dr. Yue Alexander Wu, Dr. William Pan and Dr. Faming Zhang in 2006 and is headquartered in Santa Clara, CA. | Miscellaneous Commercial Services | Founder Chairman | |
Massif Partners Holdings LP
 Massif Partners Holdings LP Financial ConglomeratesFinance Massif Partners Holdings LP is an investment fund based in Greenwich, CT. | Financial Conglomerates | Corporate Officer/Principal | |
| University of Virginia | College/University | Doctorate Degree Graduate Degree | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Doctorate Degree | |
| Stanford University | College/University | Doctorate Degree Masters Business Admin | |
Index Ventures SA
 Index Ventures SA Investment ManagersFinance Index Ventures SA (Index Ventures) is a venture capital firm founded in 1996 by Neil Alexander Rimer, Gluseppe Zocco and Gerald Rimer. The firm is headquartered in Geneva, Switzerland. | Investment Managers | Corporate Officer/Principal Private Equity Analyst | |
Apex Healthcare, Inc.
 Apex Healthcare, Inc. Internet Software/ServicesTechnology Services Apex Healthcare, Inc. provides web based managed care technology and administrative service solutions. Its services include on-line eligibility, claims and utilization review data, information management, and enrollment and eligibility administration. The company was founded in 1996 and is headquartered in Bolingbrook, IL. | Internet Software/Services | Corporate Officer/Principal | |
| University of Cincinnati (Ohio) | College/University | Doctorate Degree | |
| AMBRX INC | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
| Tsinghua University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree | |
| Jilin University | College/University | Undergraduate Degree | |
| Zhejiang University | College/University | Undergraduate Degree | |
| Fudan University | College/University | Undergraduate Degree Corporate Officer/Principal Undergraduate Degree Doctorate Degree | |
Hongshan
 Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong. | Investment Managers | Private Equity Investor | |
National Foundation for Cancer Research
 National Foundation for Cancer Research Miscellaneous Commercial ServicesCommercial Services The National Foundation for Cancer Research is a non-profit organization that provides funding to scientists for cancer research. The non-profit company is based in Bethesda, MD. The company's mission is to support life-saving discoveries for cancer patients. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
Hutchison MediPharma Ltd.
 Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Medical Specialties | Chief Executive Officer Corporate Officer/Principal | |
| Bristol-Myers Squibb (China) Pharmaceuticals Co. Ltd. | Corporate Officer/Principal Corporate Officer/Principal | ||
Akamis Bio Ltd.
 Akamis Bio Ltd. BiotechnologyHealth Technology Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director of Finance/CFO Director/Board Member | |
| The Chinese Biopharmaceutical Association | Founder Sales & Marketing | ||
MISSION Therapeutics Ltd.
 MISSION Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology MISSION Therapeutics Ltd. develops small molecule drugs targeting enzymes involved in cancer and other diseases. It focuses on selectively targeting deubiquitylating enzymes to treat cancer, neurodegenerative and other diseases. The company was founded by Stephen Jackson Philip, Xavier Jacq, Niall M. B. Martin and Keith Menear in 2011 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| ADAGENE INC. | Pharmaceuticals: Major | Director/Board Member | |
Eight Roads Ventures Japan
 Eight Roads Ventures Japan Investment ManagersFinance Eight Roads Ventures Japan is a Private Equity/Venture Capital firm, a subsidiary of FIL Ltd. founded in 2008. Eight Roads Ventures Japan is headquartered in Tokyo. | Investment Managers | Corporate Officer/Principal | |
Cenova Ventures
 Cenova Ventures Investment ManagersFinance Cenova Ventures is an independent venture capital firm headquartered in China. The firm was founded by Dr. Jun Wu in 2010. | Investment Managers | Chairman Corporate Officer/Principal | |
| JHL BIOTECH, INC. | Pharmaceuticals: Major | Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| University of Virginia Darden School of Business | College/University | Masters Business Admin Masters Business Admin | |
| Stanford Graduate School of Business | College/University | Masters Business Admin Graduate Degree | |
Inotrem SA
 Inotrem SA BiotechnologyHealth Technology Inotrem SA specializes in the development of therapeutic approaches based on its proprietary TREM-1 platform. The firm focuses on the control of immune reactions in acute inflammatory diseases. The company was founded by Jean-Jacques Garaud, Marc Derive and Sebastien Gibot in 2013 and is headquartered in Paris, France. | Biotechnology | Director/Board Member Director/Board Member | |
Impresa Management LLC
 Impresa Management LLC Investment ManagersFinance Impresa Management LLC(Impresa Management) is a Private Equity/Venture Capital firm, a subsidiary of Devonshire Investors LLC founded in 1946.The firm is headquartered in Boston. | Investment Managers | Private Equity Investor | |
| CROWN BIOSCIENCE INTERNATIONAL | Biotechnology | Founder Chairman | |
| PLEXBIO CO., LTD. | Medical Specialties | Director/Board Member | |
Zai Venture Partners
 Zai Venture Partners Investment ManagersFinance Zai Venture Partner is a venture capital investment firm. The firm is headquartered in Cayman Islands. It is founded by Ying Samantha Du in 2017. | Investment Managers | Founder | |
| HOOKIPA PHARMA INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| QYUNS THERAPEUTICS CO., LTD. | Biotechnology | Chairman | |
| Zhejiang Crownmab Biotech Co. Ltd. | Chairman | ||
Geneception, Inc.
 Geneception, Inc. BiotechnologyHealth Technology Geneception, Inc. provides healthcare services. The company is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member | |
Hangzhou New Horizon Health Technology Co., Ltd.
 Hangzhou New Horizon Health Technology Co., Ltd. Medical SpecialtiesHealth Technology Hangzhou New Horizon Health Technology Co., Ltd. is a private company that develops, manufactures, and wholesales medical diagnostics equipment for cancer screening. The company is based in Hangzhou, China. | Medical Specialties | Director/Board Member Director/Board Member | |
Maijin Biomedical Technology (Shanghai) Co., Ltd.
 Maijin Biomedical Technology (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Maijin Biomedical Technology (Shanghai) Co. Ltd. provides immunology-related therapeutic areas in China. The company is headquartered in Shanghai, China. | Miscellaneous Commercial Services | Director/Board Member | |
Zhejiang Innoforce Pharmaceuticals Co., Ltd.
 Zhejiang Innoforce Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Zhejiang Innoforce Pharmaceuticals Co., Ltd. is a Chinese company that specializes in enabling the innovation and supply of RNA, plasmid DNA, cell and gene therapeutics. The private company is based in Hangzhou, China. The company has a world-class manufacturing and development hub that provides CDMO services. | Pharmaceuticals: Major | Director/Board Member | |
| NEW HORIZON HEALTH LIMITED | Medical/Nursing Services | Director/Board Member Founder | |
| APOLLOMICS, INC. | Pharmaceuticals: Major | Chief Executive Officer |
Statistieken
Internationaal
| Verenigde Staten | 25 |
| China | 16 |
| Zwitserland | 3 |
| Verenigd Koninkrijk | 3 |
| Taiwan | 3 |
Sectoraal
| Health Technology | 22 |
| Consumer Services | 13 |
| Finance | 9 |
| Commercial Services | 5 |
| Technology Services | 2 |
Operationeel
| Director/Board Member | 210 |
| Corporate Officer/Principal | 112 |
| Founder | 48 |
| Chairman | 42 |
| Independent Dir/Board Member | 33 |
Sterkste connecties
| Insiders | |
|---|---|
| Mahendra Shah | 34 |
| Jun Wu | 30 |
| John Diekman | 29 |
| Wing Yu Leung | 27 |
| Guo-Liang Yu | 27 |
| Graziano Seghezzi | 26 |
| Kai Xian Chen | 20 |
| Jinzi Wu | 20 |
| Gilles Nobécourt | 19 |
| Eva-Lotta Allan | 17 |
| Yi Ning Zhao | 16 |
| Peter Wirth | 15 |
| Yi You Chen | 15 |
| Teri Loxam | 14 |
| James Xue | 14 |
- Beurs
- Insiders
- Marietta Wu
- Bedrijfsconnecties